文献速递淋巴瘤白血病浆细胞疾病

POT1介导的长端粒综合征中的淋巴系统恶性肿瘤与克隆性

Lymphoid malignancy and clonality in the POT1-mediated long telomere syndrome.
PubMed 文献 · Blood · 2026-01-01

该研究在24个家系51例POT1突变携带者中刻画癌症表型,血液系统恶性肿瘤 prevalence 27%,以淋系亚群更常见,并与肉瘤、甲状腺癌及慢性骨髓增殖性肿瘤聚集。UK Biobank中致病性POT1变异者端粒长且淋系恶性肿瘤发生率更高(80岁时45%;HR 8.28,95%CI 5.29-13.0)。无症状携带者中B/T细胞克隆性随年龄完全外显,提示长端粒所致细胞寿命延长是淋巴瘤的遗传易感因素。

要点

  • POT1突变携带者血液系统恶性肿瘤占27%,淋系亚群更常见,且与肉瘤、甲状腺癌及慢性骨髓增殖性肿瘤聚集。
  • UK Biobank中致病性POT1变异者80岁时淋系恶性肿瘤累积发生率达45%,风险比为8.28。
  • 淋巴细胞端粒超长(>99百分位)识别致病变异敏感性58%,高于粒细胞38%;无症状携带者60%可检出B/T细胞克隆性。

核心结论

  • 长端粒所致细胞寿命延长是淋巴瘤的遗传易感因素,可解释其与实体瘤及部分骨髓增殖性肿瘤的综合征关联。

研究设计与样本

  • 研究纳入24个家系51例POT1突变携带者(中位年龄51岁,范围5-94岁)进行癌症表型分析。
  • 利用UK Biobank中致病性POT1变异参与者数据验证端粒长度与淋巴恶性肿瘤风险。

主要发现

  • 血液系统恶性肿瘤在POT1突变携带者中 prevalence 为27%,仅次于黑色素瘤,且淋系亚群更常见。
  • UK Biobank中致病性POT1变异者80岁时淋系恶性肿瘤发生率达45%,风险比8.28(95%CI 5.29-13.0)。
  • 诊断涵盖儿童/青年急性淋巴细胞白血病和霍奇金淋巴瘤,以及成人慢性淋巴细胞白血病/多发性骨髓瘤,部分家系呈常染色体显性全淋巴瘤伴遗传早现。
  • 基线淋巴细胞端粒较粒细胞长(年龄校正均值+1千碱基;P< .0001),且随衰老纵向保持。
  • 无症状POT1变异携带者中20例有12例(60%)检出B和/或T细胞克隆性,65岁以上完全外显(7/7);60岁以上携带者中9/10有临床前克隆性淋巴瘤相关改变。

关键数值与推荐

  • 淋巴细胞端粒超长(>99百分位)识别致病性POT1变异的敏感性为58%,粒细胞为38%。
  • UK Biobank致病性POT1变异者80岁时淋系恶性肿瘤累积发生率为45%,风险比8.28(95%CI 5.29-13.0)。

临床怎么用

  • 对POT1突变家系应关注淋系恶性肿瘤风险,尤其儿童/青年急性淋巴细胞白血病、霍奇金淋巴瘤及成人慢性淋巴细胞白血病/多发性骨髓瘤。
  • 淋巴细胞端粒长度检测(>99百分位)可能较粒细胞更敏感地识别致病性POT1变异携带者。
  • 60岁以上POT1变异携带者建议评估B/T细胞克隆性及临床前淋巴瘤相关改变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Long telomere length (TL) extends replicative capacity in vitro and predisposes to clonal hematopoiesis. We characterized the cancer phenotype in 51 individuals from 24 families with mutant POT1, a negative regulator of telomerase elongation (median age, 51 years [range, 5-94]). Hematologic malignancies were second in prevalence after melanoma (27%), and lymphoid subsets were more common. They clustered with history of sarcoma, thyroid cancer, and chronic myeloproliferative neoplasms. UK Biobank participants with pathogenic POT1 variants had long TL and higher lymphoid malignancy rates (45% by the age of 80 years; hazard ratio, 8.28; 95% confidence interval, 5.29-13.0). Across cohorts, diagnoses encompassed acute lymphoblastic leukemia and Hodgkin lymphoma in children/young adults and chronic lymphocytic leukemia/multiple myeloma in adults. They clustered in families manifesting as autosomal dominant pan-lymphoma with genetic anticipation at times. Lymphocyte TL was longer than granulocytes at baseline (age-adjusted mean +1 kilobase; P< .0001) and was preserved longitudinally with aging. Ultralong lymphocyte TL >99th percentile was more sensitive for identifying pathogenic variants (58% vs 38% for granulocytes). Among asymptomatic POT1 variant carriers, 12 of 20 (60%) had immunophenotype-detected B- and/or T-cell clonality, with complete penetrance after the age of 65 years (7/7). IGH CDR3 sequencing supported age-dependent pruning of the B-cell repertoire, and cytogenetic and next-generation analyses uncovered preclinical clonal lymphoma-associated changes in nearly all POT1 variant carriers aged >60 years (9/10). Our data identify extended cellular longevity due to long TL as an inherited risk factor for lymphoma, explaining its syndromic association with solid tumors and, in some cases, myeloproliferative neoplasms.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Davidson-Swinton HR, Iyer S, Kolchinski A, et al. Lymphoid malignancy and clonality in the POT1-mediated long telomere syndrome. Blood. 2026. PMID: 41564438. doi:10.1182/blood.2025031287

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。